A General and Facile Strategy to Fabricate Multifunctional Nanoprobes for Simultaneous (19)F Magnetic Resonance Imaging, Optical/Thermal Imaging, and Photothermal Therapy

19F MRI/CEUS Dual Imaging-Guided Sonodynamic Therapy Enhances Immune Checkpoint Blockade in Triple-Negative Breast Cancer

Treatment of highly aggressive triple-negative breast cancer (TNBC) in the clinic is challenging. Here, a liposome nanodrug (LP@PFH@HMME) integrating imaging agents and therapeutic agents for bimodal imaging-guided sonodynamic therapy (SDT) is developed, which boosted immunogenicity to enable potent immunotherapy via immune checkpoint blockade (ICB) in TNBC. In the acidic tumor microenvironment (TME), LP@PFH@HMME undergoes "nano-to-micro" transformation due to a pH-responsive lipid fusion, which makes droplets much more sensitive to ultrasound (US) in contrast-enhanced ultrasound (CEUS) and SDT studies. The nanodrug demonstrates robust bimodal imaging ability through fluorine-19 magnetic resonance imaging (19F MRI) and CEUS bimodal imaging, and it exhibits excellent solubility in aqueous solution with relatively high 19F content and desirable long transverse relaxation time (T2 = 1.072 s), making it suitable for high-performance 19F MRI, in addition to effective accumulation of nanodrugs after tail vein injection. Thus, 19F MRI/CEUS dual imaging is achievable to show adequate time points for US irradiation of tumor sites to induce highly effective SDT, which produces abundant reactive oxygen species (ROS) triggering immunogenic cell death (ICD) to assist ICB-based immunotherapy. The combination treatment design of sonodynamic therapy with immunotherapy effectively inhibited TNBC growth and recurrence, highlighting the promise of multifunctional nanodrugs in treating TNBC.

19 F MRI Nanotheranostics for Cancer Management: Progress and Prospects

Fluorine magnetic resonance imaging (¹⁹ F MRI) is a promising imaging technique for cancer diagnosis because of its excellent soft tissue resolution and deep tissue penetration, as well as the inherent high natural abundance, almost no endogenous interference, quantitative analysis, and wide chemical shift range of the ¹⁹ F nucleus. In recent years, scientists have synthesized various ¹⁹ F MRI contrast agents. By further integrating a wide variety of nanomaterials and cutting-edge construction strategies, magnetically equivalent ¹⁹ F atoms are super-loaded and maintain satisfactory relaxation efficiency to obtain high-intensity ¹⁹ F MRI signals. In this review, the nuclear magnetic resonance principle underlying ¹⁹ F MRI is first described. Then, the construction and performance of various fluorinated contrast agents are summarized. Finally, challenges and future prospects regarding the clinical translation of ¹⁹ F MRI nanoprobes are considered. This review will provide strategic guidance and panoramic expectations for designing new cancer theranostic regimens and realizing their clinical translation.

19 F MRI Probes for Multimodal Imaging*

Magnetic resonance imaging (MRI) is one of the most powerful imaging tools today, capable of displaying superior soft-tissue contrast. This review discusses developments in the field of ¹⁹ F MRI multimodal probes in combination with optical fluorescence imaging (OFI), ¹ H MRI, chemical exchange saturation transfer (CEST) MRI, ultrasonography (USG), X-ray computed tomography (CT), single photon emission tomography (SPECT), positron emission tomography (PET), and photoacoustic imaging (PAI). In each case, multimodal ¹⁹ F MRI probes compensate for the deficiency of individual techniques and offer improved sensitivity or accuracy of detection over unimodal counterparts. Strategies for designing ¹⁹ F MRI multimodal probes are described with respect to their structure, physicochemical properties, biocompatibility, and the quality of images.

Fluorine Labeling of Nanoparticles and In Vivo 19F Magnetic Resonance Imaging

Fluorinated nanoparticles have increasing applications, but they are still challenging to prepare, especially in the case of water-soluble fluorinated nanoparticles. Herein, a fluorine labeling strategy is presented that is based on the conjugation of custom-made small fluorinated building blocks, obtained by simple synthetic transformations, with carboxylated gold nanoparticles through a convenient phase-transfer process. The synthesis of four fluorinated building blocks with different chemical shifts in ¹⁹F nuclear magnetic resonance and varied functionalities is reported, along with their conjugation onto nanoparticles. Fluorinated nanoparticles of small core size obtained by this conjugation methodology and by direct synthesis presented high transverse relaxation times (T₂) ranging from 518 to 1030 ms, and a large number of equivalent fluorine atoms per nanoparticle (340-1260 fluorine atoms), which made them potential candidates for ¹⁹F magnetic resonance related applications. Finally, nontargeted fluorinated nanoparticles were probed by performing in vivo ¹⁹F magnetic resonance spectroscopy (¹⁹F MRS) in mice. Nanoparticles were detected at both 1 and 2 h after being injected. ¹⁹F MRI images were also acquired after either intravenous or subcutaneous injection. Their fate was studied by analyzing the gold content in tissues by ICP-MS. Thus, the present work provides a general fluorination strategy for nanoparticles and shows the potential use of small fluorinated nanoparticles in magnetic-resonance-related applications.

LSPR effects in a magnetic–luminescent heterostructure for efficient enhanced luminescence performance

In this study, a novel core–shell structured nanocomposite of WO₃ intermediate with LSPR was synthesized. This conclusion can solve the problems faced by magnetic–luminescent imaging materials and promote the application of this type of nanocomposites in tumor therapy.

In vivo drug tracking with 19F MRI at therapeutic dose

Tracking drugs with 19F MRI would be beneficial for developing theranostics and optimizing drug therapy. To this end, a fluorinated dendritic amphiphile with high 19F MRI sensitivity and biocompatibility has been developed for 19F MRI tracking of doxorubicin (DOX)-loaded liposomes in mice, which may provide an effective platform to in vivo trace various drugs with 19F MRI.

Potential detection of cancer with fluorinated silicon nanoparticles in 19F MR and fluorescence imaging

Novel fluorinated silicon nanoparticles with strong fluorescence, high ¹⁹F-MRI sensitivity and excellent aqueous solubility have been successfully developed.

Exploration of photothermal sensors based on photothermally responsive materials: a brief review

Photothermal sensors have emerged as a new type of sensor platform in recent decades and this brief review has summarized different types of photothermally responsive materials and their applications in various fields.

A pH-responsive nanoprobe for turn-on 19F-magnetic resonance imaging

A pH-responsive MRI nanoprobe was developed by partially replacing organic linkers in ZIF-8, which displays pH-responsive in vivo¹⁹F MRI ability.

Continuous and scalable fabrication of stable and biocompatible MOF@SiO2 nanoparticles for drug loading

A novel thermal-assisted microfluidic system was developed for the continuous and scalable production of drug@MOFs@SiO₂ nanoparticles for in vivo anti-tumor therapy.

Multifunctional nanoprobes for both fluorescence and 19F magnetic resonance imaging

Fluorescence is widely used for cell imaging due to its high sensitivity and rich color choice but limited for in vivo imaging because of its low light penetration. Meanwhile, magnetic resonance imaging (MRI) is widely applied for in vivo diagnosis but not suitable for cell imaging because of its low resolution. Compared to ¹H-MRI, ¹⁹F-MRI is more suitable for clinical application due to its high sensitivity but fabricating ¹⁹F-MRI probes is a great challenge. Therefore, it is highly desirable to develop a dual-modal imaging probe for both cell fluorescence imaging and in vivo¹⁹F-MRI with high sensitivity and deep penetration. In this study, ¹⁹F moiety loaded nanocomposites with an organic fluorescent core were successfully prepared via a facile strategy by encapsulating organic dyes with oleylamine-functionalized polysuccinimide and 1H,1H,2H,2H-perfluorodecyltriethoxysilane (PDTES). The aggregation of organic fluorescent dyes in the core results in significant fluorescence for optical imaging, while the ¹⁹F moieties on PDTES allow for simultaneous ¹⁹F MRI. Moreover, the nanocomposites exhibited high water dispersibility and excellent biocompatibility. These properties make them promising for both cell imaging and in vivo imaging applications.